E6-19263. Agency Forms Undergoing Paperwork Reduction Act Review

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at [phone] or send an e-mail to [e-mail]. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to [phone]. Written comments should be received within 30 days of this notice.

Proposed Project

National Disease Surveillance Program I—Case Reports—Revision—(OMB No. 0920-0009), National Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

Formal surveillance of 19 separate reportable diseases has been ongoing to meet the public demand and scientific interest in accurate, consistent, epidemiologic data. These ongoing disease reports include: Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob Disease(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. Tularemia and Methicillin-Resistant Staphylococcus aureaus (MRSA) are new additions to this submission. Case report forms from state and territorial health departments enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. This information is used to direct epidemiologic investigations, identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and develop guidelines for prevention and treatment. The data collected will also be used to recommend target areas most in need of vaccinations for selected diseases and to determine development of drug resistance.

Because of the distinct nature of each of the diseases, the number of cases reported annually is different for each. There is no cost to respondents other than their time. The total annual burden hours are 13,371.

Estimate of Annualized Burden Hours

Form	Number of respondents	Number responses/ respondent	Total responses	Hrs/response
ABCs	329	21	6,909	10/60
ABCs Invasive MRSA	18	256	4,608	10/60
CJD	20	2	40	20/60
Cyclosporiasis	55	10	550	15/60
Dengue Case Investigation	55	182	10,010	15/60
Hantavirus Pulmonary Syndrome	46	3	138	20/60
Idiopathic CD4+T-lymphocytopenia	10	2	20	10/60
Kawasaki Syndrome	55	8	440	15/60
Legionellosis Case Report	23	11.7	269	20/60
Lyme Disease Report	52	385	20,020	10/60
Malaria Case Surveillance Report	55	20	1,100	15/60
Plague Case Investigation Report	55	0.20	11	20/60
Q Fever	55	1	55	10/60
Reye Syndrome Case Surveillance Report	50	1	50	20/60
Tick-borne Rickettsial Disease Case Report	55	18	990	10/60
Trichinosis Surveillance Case Report	55	.45	25	20/60
Tularemia	55	2.2	121	20/60
Typhoid Fever Surveillance Report	55	6	330	20/60
Viral Hepatitis Case Record	55	200	11,000	25/60

Dated: November 8, 2006.

Joan F. Karr,

Acting Reports Clearance Officer, Centers for Disease Control and Prevention.